Researchers at the University of California San Diego have discovered that two commonly used stem cell therapies, BMAC and ADSVF, contain different types of cells. These findings challenge the current practice of using these therapies interchangeably and emphasize the need for more in-depth characterization of stem cell therapies before they are used in patients. The study found that both therapies have low concentrations of mesenchymal stem/stromal cells and different overall compositions. The lack of standardized dosages and defined active ingredients highlights the need for more rigorous research in the field of stem cell therapy. The researchers’ findings provide a valuable resource for future studies and suggest the need for more standardized cell therapies.
Source link
Common therapies contain different cell types, study finds
